These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 326651)

  • 1. [Experimental principles of immunotherapy using microbial substances in malignant tumors. 1. Effect of streptococci on ascite retothelsarcoma in the mouse in vitro].
    Huth E
    Fortschr Med; 1977 May; 95(20):1359-64. PubMed ID: 326651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental principles of immunotherapy in malignant tumors using microbial substances. 2. Effect of streptococci on ascites-rethotelsarcoma of the mouse in vitro].
    Huth E
    Fortschr Med; 1977 Jun; 95(21):1409-12. PubMed ID: 873421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Clostridium toxoids, especially of Clostridium perfringens toxoid, on mouse transplanted tumors.
    Sasaki T; Chihara G; Takasuka N; Suzuki S
    Gan; 1976 Apr; 67(2):275-7. PubMed ID: 184006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a bacterial vaccine on tumors and the immune response of ICR/Ha mice.
    Havas HF; Schiffman G; Bushnell B; Dellaria M; Axelrod RS; Shanahan T; Burns MM; Guan CF
    J Biol Response Mod; 1990 Apr; 9(2):194-204. PubMed ID: 2187952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antitumor action of bacterial extracts. II. Suppressive effects of extracts of E. coil on subcutaneous tumors of mouse.
    Watanabe T; Sakamoto I
    Jpn J Exp Med; 1982 Feb; 52(1):39-44. PubMed ID: 6752491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The kinetics of reticulosarcomatosis development in mice and the effect of chemotherapeutic preparations].
    Dronova LM; Belich EI; Erokhin VN
    Izv Akad Nauk SSSR Biol; 1976; (1):140-4. PubMed ID: 767388
    [No Abstract]   [Full Text] [Related]  

  • 7. Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia, chemotherapy, or immunotherapy.
    Haranaka K; Sakurai A; Satomi N
    J Biol Response Mod; 1987 Aug; 6(4):379-91. PubMed ID: 3625230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
    Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
    Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced antitumor and immune-adjuvant activities of the sub-cellular fractions from Group A Streptococcus.
    Ryoyama K; Natsuume-Sakai S; Hirota H; Koshimura S
    Jpn J Exp Med; 1981 Dec; 51(6):335-44. PubMed ID: 7040746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference of alpha-hemolytic streptococci isolated from tonsillar surface on beta-hemolytic streptococci (Streptococcus pyogenes)--a methodological study.
    Grahn E; Holm SE; Ekedahl C; Roos K
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Jul; 254(4):459-68. PubMed ID: 6372328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant antitumoral activity of cationic multilamellar liposomes containing human IFN-beta gene against human renal cell carcinoma.
    Nakanishi H; Mizutani Y; Kawauchi A; Ukimura O; Shiraishi T; Hatano M; Mizuno M; Yoshida J; Miki T
    Clin Cancer Res; 2003 Mar; 9(3):1129-35. PubMed ID: 12631618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types.
    Papa MZ; Mulé JJ; Rosenberg SA
    Cancer Res; 1986 Oct; 46(10):4973-8. PubMed ID: 3489517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strain differences in the antitumor activity of an immunopotentiator, Nocardia rubra cell-wall skeleton, in B10 congenic and recombinant mice.
    Haraguchi S; Kurakata S; Matsuo T; Yoshida TO
    Jpn J Cancer Res; 1985 May; 76(5):400-13. PubMed ID: 2989065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The history of leukaemia therapy.
    Storti E
    Haematologica; 1978 Feb; 63(1):74-85. PubMed ID: 417974
    [No Abstract]   [Full Text] [Related]  

  • 15. The immunological basis of tumor rejection: the absolute dependence of the effector arm on sensitized T cells after chemoimmunotherapy of a murine sarcoma.
    Evans R; Duffy T
    J Immunol; 1985 Jun; 134(6):4255-60. PubMed ID: 3872913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study of antitumor chemotherapeutic agents -synthesis of cantharidine derivatives (author's transl)].
    Liu JY; Zhang BX; Li RX
    Yao Xue Xue Bao; 1980 May; 15(5):271-7. PubMed ID: 7006314
    [No Abstract]   [Full Text] [Related]  

  • 17. Substances with antineoplastic activity. XCVI. Some pharmacological properties and therapeutic synergism of 6-purinyl-N-(2-chloroethyl)thiocarbamate with cytosine arabinoside.
    Mĕlka M; Krepelka J; Miko M; Pokorná S; Kejhová I; Reichlová R; Beitová M; Grimová J; Kargerová A; Sedivá J
    Neoplasma; 1989; 36(4):419-25. PubMed ID: 2671756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New immunotherapeutic approaches for the treatment of anaplastic large cell lymphoma in a mouse model].
    Bittner C; Merz H; Krokowski M; Briese J; Wiedemann GJ; Feller AC
    Verh Dtsch Ges Pathol; 2000; 84():187-98. PubMed ID: 11217440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of recombinant human interferon-alpha A/D on the growth of experimental tumors in mice].
    Ootsu K; Kozai Y; Houkan T; Gotoh K; Matsutani E
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2502-8. PubMed ID: 3304169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
    Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
    Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.